Member Info for Cars

Sounds pricey compared to a little jab ! Is it in principle the same as TCR ?

Just had my top up at 5.95 , looking forward to next week .

Have a good weekend all .

Hi C7 ,
In reply to your 11.27 - no not mine , was tempted into the close at 6.08 , will prob have ago tomorrow. Monday will be a month since Covidity RNS so I would have thought we would get some news soon .

Hi C7 ,
I am expecting good news to come in before any raising ! Does not make sense to me to raise before Good news , we are not desperate for money and could happily last till later in the year ! We have potentially loads of positive good news to come and only really a fund raise ( that we are aware of ) that some could say is negative, so in my mind the upside hugely out ways the down and at 6 p there is not a lot of down but could be a very big up !
Time will tell !

Afternoon,
Two more 300 k trades just appeared . Getting close to another topee upee time me thinks !

Maybe of interest to some , we don’t appear yet but that’s probably due to lack of funding , once that’s sorted we should do . Was surprised not to see us in either pre- clinical or at least early research .

https://www.raps.org/news-and-articles/news-articles/2020/3/covid-19-vaccine-tracker

Afternoon,

I completely agree with what is being said about simplifying the science in the media and like Ray said staying clear of certain words like “ hopefully and maybe “, using these words almost detracts from the science , we all hope that something great will happen but far too often our hopes never materialise ! We know nothing is proven until it is proven but there are two markets any company has to play to and in our case it is the scientific community and the share/ funds market and they are different animals . Our science is great , fabulous, fantastic, cutting edge , life changing etc but how many people really get it ?
I was 20 years in sales and a very basic selling technique was “ features and benefits “ ie what it is or does and how will it benefit you / me ? Keep it simple for the masses , if your selling a car 99% of people don’t give a monkeys about all the technical stuff going on under the bonnet but they do care about how it makes them feel , how successful they feel ,if it saves them money , is it practical for their needs etc and the principle for Sclp is the same . If your talking to pharma get technical, if your talking to the market get simple ! All imo .

Have a good weekend and maybe next week !

Hi Inan,
Yes that was what I was asking , thanks .

Morning,
Quick question .
In late stage cancer patients , would it be possible to combine Moditope and our COVID vaccine ? either in a single dose or separately ? Or is it too early to know ?
Also assuming our combination trial with Keytruda was successful, would we be able to treat those cancer patients with Immunobody and our covid vaccine ?
I suppose what I am asking is would it be possible to combine the treatments to attack cancer as well as covid ?
This is obviously hypothetical and assuming our trials are successful and we are able to produce a successful covid vaccine .

Thanks in advance .

Morning all ,
Mainly for newbies -
This has probably already been posted but explains Scancells approach against Covid19 but also if you click on “notes for editors “ it also explains about our other platforms and how impressive they really are .

https://www.ntu.ac.uk/about-us/news/news-articles/2020/04/universities-in-nottingham-to-play-a-key-role-in-the-development-of-a-potential-dna-vaccine-against-covid-19

MMS happy to take 288k + now

Afternoon ,
Good news again today , think we may well see more to come !

MM’s happy to take in excess of 275k shares so me thinks they maybe a little light at the mo ! Sure we will see a little tree shake !

Afternoon Drac ,
I am happy to retract my comment about gold . The reason I made it was when you said “ Isn't It a Pity that Sclp Didn't specialize on Virus Vaccines when No progress was being made with SCIB1” I took it that you were being cynical and as that was a misunderstanding on my behalf you have my apologies .
As far as Lindy demoting herself - no I do not .

Differing views though is what discussion is all about .

Morning Drac ,
I wouldn’t pay too much attention to Tw imo , we have a bit of history with him and it’s fairly obvious he does not like us , from memory he called us ‘ a bunch of snobs who are up themselves ‘ ( or words to that effect ) he has also stated that he doesn’t really understand the science so he only really concentrates on balance sheet !
As far as jumping on the bandwagon ! I find this comment very degrading to Lindy and the whole team , here we are in the middle of a pandemic , we may have the technology that really could make a difference and he thinks we are just using it as a way to pump our price up !
He may be right and time will tell but imo he is way off the mark ! The company has already stated they are looking for non dilutive funding for Cov vaccine and there is a good chance of licensing deals coming on the back of our other platforms so imo a raise might not be happening for a while if at all .
Regarding your Comment about maybe they should specialise in Virus vaccines ? Why would they ? They specialise in cancer vaccines which , as mentioned before , is considerably harder to treat than a virus . We just have the technology and experience to cross over into virus vaccines . It’s a bit like saying maybe we should have concentrated on gold mining as well because that sector has done extremely well of late and we could have raised a lot more money that way .
Have a good day .

Apologies if this has already been posted , top of the tip list .

https://www.proactiveinvestors.co.uk/companies/news/918643/small-cap-movers-coronavirus-crisis-shines-a-light-on-small-cap-pharma-918643.html

Morning ,
For newbies - a very very very basic overview of Sclp before the Covid19 RNS .

Platform 1 - Immunobody - effectiveness in early stage cancers - lead product Scib1 in Melonoma , proven to be safe with no side effects and fantastic results in stage 3+4 patients - majority of patients lived beyond 5 yrs ( potentially cured )
2nd product - Scib2 which is targeting Nsclc ( lung cancer ) . This is due into trial end of this year / early next year ( from memory ) . This is being run by CRUK who will design and run the trial at their expense ! Once completed Sclp have the option to purchase the rights back for a nominal fee( unknown) .
There are more potential targets in Immunobody and if I am correct it’s a bit like snap on tools - if you want to target another cancer you can tweak the vaccine back in the lab .
Immunobody is designed to boost your own immune system to fight against cancer . Vaccine generally in the past have been unable to generate enough of a response to have any effect against cancer but Sclp have overcome this issue and the technology is patented . Immunobody also has a memory affect , so if you present it again with cancer it will attack the cancer again .

Platform 2 - Moditope . The jewel in the crown - Lindy’s baby - Lindy has never seen anything quite as powerful in her 30+ yrs !
Moditope’s potential is in late stage cancers and in mice models has destroyed cancer ! Due into Human trial early next year ! This was a serendipitous find and has taken 8 yrs from discovery to first in trial . It’s potential is far reaching and looks like it could cross over into other areas such as chronic diseases etc , maybe even Rheumatoid arthritis. It has proven to be incredibly powerful in mice models and if this transfers into humans this will be incredibly significant in finding a cure for cancer ( potentially all cancers ) .
Moditope is very versatile and we are currently in a collaboration with Biontech who are possibly looking to use it within their own TCR platform .

Platform 3 - AvidiMab - well this is new but has already sparked a lot of interest inc 3 scientific collaborations with an American , Chinese and one unknown company . I won’t pretend I understand the science behind this platform but it could well produce our first or any number of licensing deals .

So we have one platform that targets early stage and one that targets late stage and within those platforms we have many potential cancer targets and it only takes one to be successful and you can kiss goodbye to 10p a share ( many shots on goal , it only takes one to go in ) .

This all takes money and to date we have not achieved a licensing deal but that does not mean one or more are not coming ! Vaccines 5+ yrs ago had a shocking time in pharma world and funding has been hard - some high profile failures due to lack of response , however times have changed , vaccines are back in vogue and Immunobody increase response rates !
All imo and happ

Ruck not Uk

Have to agree C7 that more news will be forthcoming soon , any hint of good news and this really could go , a lot of LTH’s have spent years taking positions and can’t see them giving them away cheaply ! I remember when you had a target holding of 80 k and you’ve passed 220 k ( I think ) , Crumbs adding small weekly amounts but now has amassed a good size holding !
Uk mentioned 64 p the other day and I had a chuckle , Oct 2012 , I bought and down she goes ! Sorry about that ! Different days ahead imo . Gla

Been here 7.5 yrs , first purchase was 64p! Lowest purchase 3.9 p ( courtesy of our ii who went into admin and offloaded 11 million shares ) with avg just over 10.5p and have been happy to do it , admittedly never expected to have to wait soooo long to see some sort of return but that maybe the case soon . It has been a long , tiring and very very frustrating journey , But I am now hopeful that a lot of LTH’s and certainly newbies will be able to make a decent ROi .
May sound like a ramper now but C7 Your 50 p target certainly is achievable imo - when ? Well I’ve stopped trying to predict that !

Some solid buying on Nex at the mo , looks like the market isn’t too worried about the tiny sell off after all !

Make that 6.68 !